Answers are grounded in this paper and cite their sources.
Research identifies and validates a radiotracer for non-invasive imaging of atherosclerotic plaque in humans, indicating potential for high-risk detection.
Extracellular arterial activity of the pro-inflammatory enzyme myeloperoxidase (MPO) destabilizes atherosclerotic plaque and associates with future atherothrombosis. To facilitate first-in-human studies using extracellular MPO activity as a molecular imaging target to identify high-risk atherosclerotic plaque, we describe [⁶⁸Ga]Ga-IEMA, a NODAGA-based positron emission tomography (PET) radiotracer that provides an index for extracellular MPO activity. Synthesis of [⁶⁸Ga]Ga-IEMA was achieved in five steps and with high radiolabelling efficiency. [⁶⁸Ga]Ga-IEMA self-oligomerized and bound to proteins upon exposure to enzymatically active MPO, did not cross-cell membranes and was stable in human serum in vitro, while [⁶⁸Ga]Ga-IEMA had favorable blood kinetics and stability in circulation in vivo. [⁶⁸Ga]Ga-IEMA PET imaging in a mouse model of plaque instability revealed enhanced signal in unstable compared with stable plaque and plaque-free arteries. These data indicate that [⁶⁸Ga]Ga-IEMA is a promising translational candidate for the non-invasive identification of high-risk atherosclerotic plaques and the evaluation of therapies targeting arterial inflammation.
No takes yet. Share an insight, caveat, or question.
Keeling et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: